Case Reports
Schizophrenia and severe tardive dyskinesia responsive to risperidone
- PMID: 7533794
Item in Clipboard
Case Reports
Schizophrenia and severe tardive dyskinesia responsive to risperidone
J Clin Psychopharmacol.
1994 Dec.
No abstract available
Similar articles
-
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.J Clin Psychopharmacol. 1993 Feb;13(1):25-40. J Clin Psychopharmacol. 1993. PMID: 7683702 Clinical Trial.
-
New drug offers hope for people with schizophrenia.J Psychosoc Nurs Ment Health Serv. 1994 May;32(5):46. J Psychosoc Nurs Ment Health Serv. 1994. PMID: 7519676 No abstract available.
-
Risperidone: clinical safety and efficacy in schizophrenia.Psychopharmacol Bull. 1992;28(2):213-8. Psychopharmacol Bull. 1992. PMID: 1381102 Clinical Trial.
-
Clinical considerations in the use of risperidone.Can J Psychiatry. 1993 Sep;38 Suppl 3:S96-100. Can J Psychiatry. 1993. PMID: 7504575 Review.
-
New antipsychotic medications: do research results relate to clinical practice?Can J Psychiatry. 1993 Sep;38 Suppl 3:S75-9. Can J Psychiatry. 1993. PMID: 7504572 Review.
Cited by
-
Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.J Autism Dev Disord. 1997 Aug;27(4):479-89. doi: 10.1023/a:1025813607005. J Autism Dev Disord. 1997. PMID: 9261670 No abstract available.
-
The Canadian experience with risperidone for the treatment of schizophrenia: an overview.J Psychiatry Neurosci. 1998 Sep;23(4):229-39. J Psychiatry Neurosci. 1998. PMID: 9785702 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical